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Whole Genome Association Studies (WGASs)  offer a systematic strategy to assess the 
influence of common (minor allele frequency ≥ 5%) genetic variants on phenotypes 
(Risch and Merikangas 1996). Most variants tested will not be associated to any 
particular phenotype, but may produce false positive association signals, masking 
potential true positives. Forecasting these null-distribution of false-positives is important 
as a practical guideline for interpreting genomewide association scans, akin to classical 
work (Lander and Kruglyak 1995) directing linkage analysis. The concrete question is, 
given an association signal of a certain nominal p-value, how unlikely is it in a WGAS?  
 
Naïve, Bonferroni (Sidak 1967) corrections for standard testing of multiple, independent 
hypotheses are overconservative in this context: local correlation among these tests 
means that effectively there are considerably less independent tests than Single 
Nucleotide Polymorphisms (SNPs) examined. Theoretical (Tavare et al. 1997) and 
simulation studies (Lin et al. 2004) relate the number of such tests to the number of 
historical recombinations, estimated to be much smaller. Yet, no previous systematic 
evaluation of the testing burden.is available.  
 
Such an evaluation is particularly critical to the standard, two step design for WGASs 
(Thomas et al. 2004; Skol et al. 2006) that does not lend itself to significance evaluation 
by permuting phenotypic labels. In this design common variation is first screened for 
association signals using cost-effective typing of hundreds of thousands of SNPs (Barrett 
and Cardon 2006; Pe'er et al. 2006). Next, regions of potentially positive signals are 
followed-up with denser, saturated SNP sets, in order to validate, refine and strengthen 
the associations. As well worked out in linkage analysis (Kruglyak and Daly 1998), this 
directed increase in marker density around positives alters the null signal distribution 
with the practical effect of mimicking a WGAS of all 6-7 million common SNPs. Hence, 
permuting data with only the smaller, typed set of SNPs underestimates expected false 
positives. 
 
The testing burden associated with examining all common alleles does lend itself to  
empirical evaluation from data, thanks to the Human Haplotype Map (HapMap) 
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ENCODE regions (Altshuler et al. 2005). These regions offer near-complete description 
of common SNPs (Pe'er et al. 2006), and allow simulating association studies with no 
true signal (de Bakker et al. 2005). More specifically, we generate the genetic data for a 
simulated (case or control) individual at an ENCODE region by randomly pairing two of 
the phased chromosomes available from HapMap trios for that region. We repeat this to 
obtain 2000 individuals randomly labeled cases or controls, mimicking a null study. The 
maximal-scoring difference in allele frequencies between “cases” and “controls” across 
all SNPs in such a region is evaluated for significance, and the p-value distribution is 
estimated by repeating the simulation 107 times. This distribution observes more 
significant p-values then theoretically distributed p-values for a single test statistic due to 
multiple testing. We repeat this evaluation procedure for the trio-base HapMap 
populations (CEU and YRI), for all ENCODE regions, and for different cohort sizes. The 
per-region testing burden is the factor by which significance is exaggerated. As 
ENCODE regions represent the genomewide average recombination and mutation rates, 
we can extrapolate to estimate the genomewide testing burden in such an association 
study. 
Figure 1a reports the extrapolated number of independent tests required to mimic the 
expectation of the best p-value in a WGAS, i.e. the empirical testing burden. For all 
common SNPs, we find the testing burden to be considerably lower than available 
bounds1, at half million tests in the HapMap European (CEU) samples. This means, for 
instance, that the probability of a WGAS in a European population that examines all 
common alleles to exhibit, by random chance alone (no true genetic effect), a result with 
p-value<10-7 is smaller than 0.05. In the HapMap African (YRI) samples, that have more 
SNPs, and less linkage disequilibrium, testing burden is higher at one million. Since 
                                                 
1 The formula Log(k)× Ne×R in  
Tavare S, Balding DJ, Griffiths RC, Donnelly P (1997) Inferring coalescence times from DNA sequence 
data. Genetics 145(2): 505-518. esti,mates 1.1million common recombinations in Europeans, where: 
   - k is the number of coalescence branches considered the reciprocal of the minor allele frequency 
threshold for sites considered, i.e.  k = 20 for common SNPs. 
   - Ne is the effective population size , ~10,000 in Europeans 
   - R is the average number of recombination events per meiosis,  36 [8]  
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ENCODE data are still incomplete w.r.t. rare variants, they provide only a lower bound 
on their associated testing burden, showing it to be more than 2-fold higher than for 
common alleles. 
 
ENCODE regions deliberately represent a variety of genomic characteistics (The 
International HapMap Consortium 2003), and also testing burden varies greatly from 
region to region. Yet, testing burden is not strongly correlated with neither the actual 
number of common SNPs in the particular region, nor the regionwide recombination rate 
(Fig 1b).  
 
It is important to realize that testing burden is not constant across p-values: association 
signals with more extreme p-values involve more burden (Fig 1c). This is because the 
power of such signals to distinguish better between partially correlated tests, resulting in 
more testing burden. With weaker signals, correlated tests are undistinguishable, hence 
testing burden is reduced. This means the best practice for correcting a nominal p-value 
for the entire genome is to use a lookup-table, rather than a fixed correction factor. 
Fortunately, the first stage of a WGAS is designed for a true positive to reach only a 
moderate p-value, expected to be achieved be numerous sites (Skol et al. 2006). Such a 
stage would require less correction for multiple testing than the final stage aiming at 
genomewide significance. Finally, studies of larger size show more burden of multiple 
testing (Supplementary fig 1). We hypothesize that this effect is also related to the 
increased power of larger studies to distinguish highly- (but not perfectly-) correlated 
causal variants. 
These and other results offer considrable understanding of the distribution of null signals 
in idealized association studies. Practical association studies may exhibit more extreme p-
values then predicted by our study even without real effects due to demographical and 
genotyping technology differences between cases and controls that create artifactual hits.  
Furthermore only the accumulating experience in such studies will reveal more about the 
complementary parameters describing the alternative hypothesis, which speak to the 
number and strength of true signals. Together, the distribution of null and true signals 
will enable rigorous decision whether a given result indicates true association. 
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Figure 1 legend: A. The empirical testing burden (y-axis) for all common SNPs in 
different ENCODE regions in the HapMap panels of Yorubans from Ibadan, Nigeria 
(YRI; green) and CEPH individuals of European ancestry fro Utah (CEU; orange). 
Testing burden is evaluated as the reciprocal of the best nominal p-value expected in a 
null study of 1000 cases, 1000 controls extrapolate to the entire genome, as extrapolated 
from ENCODE. B. The testing burden (y-axis) of each region as a function of the 
region’s length in centiMorgans (x-axis, left) or of the number of SNPs tested (x,axix, 
right) C. The testing burden (y-axis) of all (smooth) or common (tick-marked) SNPs in a 
typical ENCODE region (ENr213), as a function of the empirically evaluated p-value (x-
axis).  
 
Supplementary Figure 1 legend: 
Testing burden (y-axis) extrapolated to the entire genome from simulated sturies different 
numbers of cases/controls (x-axis) in YRI (green) and CEU (orange) data from 
ENCODE, averaged across all regions. 
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